Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH – a double-blind randomized trial

INTRODUCTION: Currently alpha1-adrenoceptor blockers (AB) are widely used as first-line therapy to improve lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). We compared the efficacy and safety profile of tamsulosin, alfuzosin and silodosin in LUTS due to BPH. MA...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cent European J Urol
Huvudupphovsmän: Manohar, Chikka Moga Siddaiah, Nagabhushana, Mahadevappa, Karthikeyan, Vilvapathy Senguttuvan, Sanjay, Ramachandra Pudakalkatti, Kamath, Ananth Janardhan, Keshavamurthy, Ramaiah
Materialtyp: Artigo
Språk:Inglês
Publicerad: Polish Urological Association 2017
Ämnen:
Original Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510335/
https://ncbi.nlm.nih.gov/pubmed/28721281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5173/ceju.2017.924
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk